183 related articles for article (PubMed ID: 31017720)
21. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
22. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
23. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
24. Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047.
Guo J; Chen M; Ai G; Mao W; Li H; Zhou J
Biomed Pharmacother; 2019 Jul; 115():108957. PubMed ID: 31082770
[TBL] [Abstract][Full Text] [Related]
25. The negative feedback between miR-143 and DNMT3A regulates cisplatin resistance in ovarian cancer.
Han X; Liu D; Zhou Y; Wang L; Hou H; Chen H; Zhang L; Chen W; Li X; Zhao L
Cell Biol Int; 2021 Jan; 45(1):227-237. PubMed ID: 33090550
[TBL] [Abstract][Full Text] [Related]
26. microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6.
Chen Y; Song Y; Mi Y; Jin H; Cao J; Li H; Han L; Huang T; Zhang X; Ren S; Ma Q; Zou Z
Apoptosis; 2020 Apr; 25(3-4):205-216. PubMed ID: 31938895
[TBL] [Abstract][Full Text] [Related]
27. MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer.
Li J; Ping Z; Ning H
Int J Mol Sci; 2012 Nov; 13(12):16053-64. PubMed ID: 23443110
[TBL] [Abstract][Full Text] [Related]
28. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
29. MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3.
Wu H; Xiao Z; Zhang H; Wang K; Liu W; Hao Q
Anticancer Drugs; 2014 Aug; 25(7):799-809. PubMed ID: 24686007
[TBL] [Abstract][Full Text] [Related]
30. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
[TBL] [Abstract][Full Text] [Related]
31. MiR-223 regulates CDDP resistance in pancreatic cancer via targeting FoxO3a.
Huang R; Song X; Wang CM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7892-7898. PubMed ID: 31599414
[TBL] [Abstract][Full Text] [Related]
32. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
33. MiR-32-5p regulates the proliferation and metastasis of cervical cancer cells by targeting HOXB8.
Liu YJ; Zhou HG; Chen LH; Qu DC; Wang CJ; Xia ZY; Zheng JH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):87-95. PubMed ID: 30657550
[TBL] [Abstract][Full Text] [Related]
34. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1.
Zeng F; Xue M; Xiao T; Li Y; Xiao S; Jiang B; Ren C
Biomed Pharmacother; 2016 Apr; 79():294-301. PubMed ID: 27044840
[TBL] [Abstract][Full Text] [Related]
35. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
[TBL] [Abstract][Full Text] [Related]
36. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.
Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
Braz J Med Biol Res; 2017 Apr; 50(5):e6359. PubMed ID: 28443990
[TBL] [Abstract][Full Text] [Related]
39. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
Xu H; Hu Y; Qiu W
Biomed Pharmacother; 2017 Mar; 87():405-411. PubMed ID: 28068630
[TBL] [Abstract][Full Text] [Related]
40. Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.
Yang YC; Liu GJ; Yuan DF; Li CQ; Xue M; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1513-1519. PubMed ID: 30840273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]